Relationship between elastin-derived peptides and the development of microvascular complications: a longitudinal

G Nicoloff1, S Baydanoff, N Stanimorova

  • 1Department of Biology and Immunology, University School of Medicine, St. Kliment Ohridski Street No. 1, 5800, Pleven, Bulgaria. vmilibrpl@mbox.digsys.bg

General Pharmacology
|November 15, 2001
PubMed

Insights

Elastin-derived peptides (EDP) showed potential associations with microvascular complications in children with Type 1 diabetes. However, this pilot study suggests more research is needed to confirm EDP as an early predictor.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Pediatrics

Background:

  • Type 1 diabetes mellitus (T1DM) is a chronic condition requiring long-term management.
  • Microvascular complications are a significant concern in diabetic patients.
  • Elastin-derived peptides (EDP) are potential biomarkers linked to vascular health.

Purpose of the Study:

  • To investigate the association between elastin-derived peptides (EDP) and the development of microvascular complications in children with T1DM.
  • To explore EDP as a potential early marker for diabetic microvascular complications.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure EDP levels in the sera of 28 children with T1DM.
  • A longitudinal follow-up of 6 years was conducted.
  • Control group comprised 24 healthy children of similar age and sex.

Main Results:

  • Ten diabetic patients exhibited elevated EDP levels, with most having diabetes for over 5 years.
  • Seven patients with increased EDP developed microvascular complications.
  • EDP levels were independently associated with age, retinopathy, and antibodies to advanced glycation endproducts (AGEs).

Conclusions:

  • This pilot study suggests a potential link between EDP and microvascular complications in pediatric T1DM.
  • The current data are insufficient to establish EDP as a reliable predictor due to study limitations.
  • Larger, longer prospective studies are required to validate the role of EDP as an early marker.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...